Let an independent agency decide what public health care pays for by comparing how much health each choice brings back
In short
- Leaders stop deciding which drugs and treatments get public money based on pressure from politicians and industry.
- An independent agency decides by comparing how much health a treatment can restore with what it costs.
- The same yardstick applies to drugs and prevention, and to illnesses of the body and of the mind.
- When something is hard to show in numbers, a citizens' panel adds extra weight and explains its reasons.
If this comes true
Money saved by passing on a new drug that was not worth its price pays for two more speech and language specialists at the town health center, and parents of children who start talking late get advice without waiting.
Perhaps
A parent of a child with a very rare illness, facing a drug left outside the yardstick, might be staring at a screen all night, searching for donations from far away.
Water so far 💧 0
The proposal in detail
This covers care paid for by taxes or public insurance: new drugs, tests, treatments and prevention programs to be added, and a review of what is already being paid for. The power to decide moves from the government, the legislature and insurance operators to an evaluation agency whose independence is guaranteed by law. Members of the agency serve limited terms, and no one who is paid by drug or medical device companies or by hospital groups can serve. For each form of care, the agency estimates how many healthy years people would gain from it and how much it would cost, and it gives priority to the uses that produce more health for the same money. The same yardstick is used for illnesses of the body and of the mind, for treatment and for prevention, and for the old and the young. However, values that are hard to show in numbers, such as concern for people near the end of life, for illnesses with no other options, and for people in a severely disadvantaged position, can be added as extra weight by a panel of citizens chosen by lottery, after they put their reasons in writing. The decisions and the data behind them are made public, and patients and companies can bring new evidence and ask for a review. The government can overturn the agency's decision, but when it does, it must explain its reasons to the legislature and name a separate source of the money needed.
BenefitsThe same money can restore health for more people
Health care money flows to the uses that produce the most health, not to the loudest voice. If makers know that a drug priced too high for its effect will not be paid for as it is, they will lower the price or run studies that show a more certain effect, and the power to set prices returns to society. The money saved goes to prevention, mental illness and local clinics, whose voices were not heard before. Comparing illnesses of the body and of the mind, and treatment and prevention, on the same yardstick itself corrects an unseen kind of discrimination. Because the decision to say no is separated from elections, politicians find it harder to make crowd-pleasing promises, and health budgets are tossed around less by election seasons. With citizens adding hard-to-count values in words, a third way of deciding appears, one that leaves it neither to calculation alone nor to the balance of power. Because the reasons for decisions are public, people can learn, along with the reasons, what their taxes and insurance payments are spent on and what was passed over.
DrawbacksComparing health by numbers leaves some people unsaved
This system means officially deciding not to pay for a particular person's treatment. For a child with a very rare illness, or for a person who places a last hope on a treatment with a small effect, it would feel like a judgment that society has abandoned them. A yardstick based on healthy years may treat unfairly older people with little life left, and people with disabilities whose health tends to be scored lower, and how far the extra weight can prevent this is not certain. If makers decide they will not be paid in this country, the release of new drugs may be delayed, and research on rare illnesses itself may shrink. Because the experts at an independent agency are not elected, it becomes unclear who should be held responsible for decisions that touch on life and death. Much of the data behind the estimates comes from company research, and changing the assumptions slightly can reverse the conclusion, so there is a danger that the look of a neutral yardstick becomes a tool for shutting down objections.
Learn the background
In every society, the money available for health care is limited. Even so, what gets paid for and what gets put off tends to be settled by the balance of power at the moment, not by a clear yardstick. When there is lobbying by makers, strong appeals from patient groups, or attention from the news, an expensive new drug can win public payment even if its effect is small. Meanwhile, plain kinds of care that few people speak up for, such as blood pressure monitoring, counseling for mental illness and dental care for children, get no budget even though they produce a lot of health cheaply. Many problems in health care, including soaring drug prices, neglect of prevention, mental illness being put last, and differences between regions, grow from this same root. It has not changed because saying
Choose them ready to accept their drawbacks too (up to 5)
It helps pay for the server and the AI's planting
This proposal was written in Japanese by AI (claude-opus-5-5, policy version 2026-10-23b) and translated by AI (claude-sonnet-5-5). Nobody has checked the facts. Read the original (日本語) How the AI writes